2008-12-22 10:35:43
From the news website of the Ministry of Agriculture show that on December 15, the Ministry of Agriculture in Jiangsu Province received a report of the veterinary department in the implementation of routine monitoring of poultry, in Hai'an, Dongtai individual farmers of the layers reared in the monitoring of the H5N1 bird Pathogenic influenza-positive samples. At present, these areas have not found bird flu.
Upon receiving the report, the immediate deployment of the Jiangsu Provincial Department of Agriculture veterinary departments to implement prevention and control measures. One positive for monitoring flocks and the surrounding areas to carry out culling of poultry have been culled 377,000 poultry. The second is to monitor the implementation of isolation. Dongtai transport ban on all poultry and Hai'an and its products, restrictions on the flow. The third is to eliminate the source of disinfection. Poultry have been culled on the farm (000) and the surrounding environment to carry out thorough disinfection to prevent the spread of the virus.
In the previous 9, the Hong Kong Special Administrative Region government Secretary for Health and Food York Chow said at a chicken farm in Yuen Long in the New Territories of the samples and feces samples of dead chickens confirmed to the H5 avian influenza virus antibody positive and No one infected with bird flu. Related outbreak has been identified as a chicken farm, chicken farms within 3 km area has been identified as infected areas, the two farms were infected with 80,000 chickens will be destroyed. The departments concerned to start the original alert response level, was promoted to a serious strain level. Hong Kong will stop the supply of live chickens within 21 days.
There are brokerage assessment of the researcher, Jiangsu, Hong Kong, the "alert" for the development of large-scale epidemic is unlikely to affect the company's share price is a major short-term stimulus. To the current scale of the outbreak, the company affecting the actual performance, but it will not reach a significant level. Shares in animal husbandry from the news that the Hong Kong avian flu, "warning" has not yet been invited to the bird flu vaccine actually caused by the impact.
Related listed companies
Shares in animal husbandry: the first is the Ministry of Agriculture have been approved by the bird flu vaccine manufacturers, the production capacity of more than 13,000,000,000 feather (000), about 60% of the gross margin products, a high-profit products. At present, formal approval by the Ministry of Agriculture 9 poultry influenza vaccine production site in Nanjing Merial (50%) and bio-ho Qianyuan (accounting for 52.92 percent) are owned subsidiary of the company. Nanjing Merial is the world's largest maker of animal vaccines, biological products Qianyuan-ho also exported to Southeast Asia, the epidemic-hit areas. Key products include companies with poultry vaccines, veterinary vaccines, special three-part vaccine, is the most wide variety of products, the largest production capacity, excellent quality, market share of the first key enterprises. In animal vaccine production has more than 20,000,000,000 were feather, accounting for more than one third of the national market share. 38,000,000 yuan invested in the construction of Jiangxi Province in line with the GMP requirements of the pig, pet vaccine production base; 42,500,000 yuan investment in the biotechnology lanzhou pharmaceutical GMP standards in line with the new production plant, the new workshop have two production lines for the production of vaccines and special Synthetic peptide vaccine designed production capacity of packaging each year 2,000,000,000 ml.
Kim Woo-group: the company's bio-pharmaceutical plant in Inner Mongolia Autonomous Region is the only animal vaccine production enterprise products, the Ministry of Agriculture is also designated special animal vaccine manufacturers, bird flu vaccine research and production capacity of UN-leading domestic level. Was the first country in the bivalent vaccine production, text, "O type - Asia 1 type foot and mouth disease bivalent vaccine strong drug" as a high-end products, the first to enter the market, the company's products led to further improve market share.
Westlands biological: people with bird flu vaccine: company and the Chinese Academy of Military Medical Sciences shared with a bird flu vaccine have been completed pre-clinical studies through the review and approval, the company pandemic influenza vaccine will enter clinical cracking stage.
Tiantan Biological (600,161) (600,161): The controlling shareholder of Beijing's Institute of Biological Products and the Chinese Academy of Military Medical Sciences will jointly bear the Chinese mainland with a second bird flu vaccine research and development projects, and final production of the vaccine may be completed by the company, is expected to The research into the transformation of those.
Zhejiang Medicine: Anti-bird flu drug company access to technology breakthroughs, new drugs that can inhibit efficient strains of avian influenza virus neuraminidase, can also be used for the treatment of a wide range of popular from the bird flu virus strain redistribution and the formation of A-type influenza Caused by strains of influenza, belonging to the internationally recognized anti-bird flu drug.
Utterback sublimation: The Ministry of Agriculture officially approved by the 9 point poultry influenza vaccine manufacturers, qingdao easy to state biotechnology companies (38%), a subsidiary of the company.
Union Central medicine: the company has been inactivated bird flu vaccine (H9 subtypes, F strain), Newcastle disease live vaccine low power (La Sota strain), six products of the Ministry of Agriculture veterinary vaccine production and put into the production of documents, With the formation of Yangzhou University, Yangzhou Wick's bio-engineering Co., Ltd. (registered capital of 58,400,000 yuan, the company accounted for 39.38%) of the main avian influenza inactivated vaccine production is expected to be an annual output of 1.6 billion poultry vaccines were feather, the annual sales income of 120,000,000 yuan, net profit of up to 27,729,000 yuan, gross margin was 60% higher profitability.
Shanghai Pharmaceutical: in Switzerland, Roche announced the opening of its anti-influenza drug treatment of avian flu drug, "Tamiflu" the right to the production, the company's controlling shareholder in the drug group in mid-December 2005 became the first authorized the production of medicine Manufacturers will have the right to produce "," Chinese version "of" Tamiflu "generic drugs, but the" Tamiflu "sales channels limited to government procurement, at present, the entire group on drug Tamiflu sales in all aspects of the company Agent to do.
No comments:
Post a Comment